Buscar en
Cirugía Española (English Edition)
Toda la web
Inicio Cirugía Española (English Edition) PAIR for Complex Hepatic Hydatid Disease
Journal Information
Vol. 93. Issue 6.
Pages e45-e47 (June - July 2015)
Vol. 93. Issue 6.
Pages e45-e47 (June - July 2015)
Scientific letter
Full text access
PAIR for Complex Hepatic Hydatid Disease
Punción, aspiración, instilación y re-aspiración en casos complejos de hidatidosis hepática
Visits
...
José Manuel Ramiaa,
Corresponding author
jose_ramia@hotmail.com

Corresponding author.
, Julián del Cerrob, Roberto de la Plazaa, Farah Adela, Jorge García-Parreñoa
a Unidad de Cirugía Hepatobiliopancreática, Servicio de Cirugía General y Aparato Digestivo, Hospital Universitario de Guadalajara, Guadalajara, Spain
b Unidad de Radiología Vascular e Intervencionista, Servicio de Radiología, Hospital Universitario de Guadalajara, Guadalajara, Spain
Article information
Full Text
Bibliography
Download PDF
Statistics
Figures (2)
Tables (1)
Table 1. Patient Characteristics.
Full Text

Cystic echinococcosis (CE) is a zoonosis caused by Echinococcus granulosus larva.1–8 The most frequently affected organ is the liver (70%–80% of patients).1–3,5,9 As there are no randomized trials, it is not clear which is the best treatment for hepatic hydatid cysts (HHC): surgery, percutaneous drainage, medication (albendazole) or observation.1–7

In 1985, a published report proposed puncture as a therapeutic option for HHC. Since then, PAIR therapy (HHC puncture, aspiration of the intracystic content, injection of scolicidal solution and reaspiration) has become consolidated as a valid treatment.1–5,8,9

We present our experience with PAIR in three complex cases of HHC.

Material and Methods

From May 2007 to December 2012, the Hepatobiliopancreatic Surgery unit at our hospital treated 107 patients with HHC: 60 were treated; 44 were under periodic observation since they were asymptomatic and presented inactive cysts, refused surgery, or were at high risk for surgery; 3 symptomatic patients were treated with PAIR.

Technique: after 7 days of treatment with albendazole (400mg orally/12h), we performed the PAIR technique. Patients were monitored and under conscious sedation with local anesthesia. An initial CT-guided puncture was done with a 22 G needle, using the Seldinger technique with a 0.018 guide, attempting to pass through part of the liver tissue. After puncture, a dilator system with a 6F sheath was inserted, through which a small quantity of liquid was suctioned (10–20cc) to decompress the cyst. The liquid was analyzed immediately with laboratory diagnostic strips in order to rule out traces of bilirubin and connection with the bile duct; if there was still any doubt, cystography was done. Other samples were sent for microbiology and cytology studies. Using the same Seldinger technique, a 12–14F catheter was inserted with a 0.035″ guide. Through this catheter, 90% of the intracystic liquid was aspirated and 2/3 of the extracted liquid was replaced with a mix of 50% absolute alcohol with hypertonic saline solution (20%), which remained in the cavity for 1h. The catheter was left in for 48h, during which time the patient was monitored in order to assess any possible complications. After radiology follow-up with a CT scan, the catheter was withdrawn.

Patients were prescribed albendazole for 1 month after the PAIR procedure (400mg orally/12h). Follow-up studies at 1, 3 and 6 months included ultrasound and/or CT scan, which were repeated every 6 months thereafter. If we observed that the cyst increased in size or caused symptoms, the procedure was repeated.

Results

Clinical characteristics are shown in Table 1. One patient presented with obstructive jaundice, and a biliary fistula was ruled out by ERCP and fistulography during PAIR (Fig. 1). The jaundice was probably a result of the compression by the large HHC. Nine months later, this patient had an increased cyst size, so a second PAIR procedure was done (Fig. 2). The second patient presented disseminated hydatidosis with a symptomatic cyst that was punctured. The third patient presented a symptomatic HHC in a small liver remnant after previous surgeries. PAIR was able to resolve the symptoms of these three patients.

Table 1.

Patient Characteristics.

  Patient 1  Patient 2  Patient 3 
Age  50  75  67 
Sex  Male  Male  Female 
CE  CE2  CE1  CE1 
ASA  II  IV  II 
Comorbidities  No  Hypertensive heart disease; EF 30%  Fibromyalgia 
Previous surgeries  4 surgeries:– Multiple Lagrot×No  3 surgeries:– Lagrot×2– Left hepatectomy 
Symptoms  Right flank pain  Obstructive jaundice  Abdominal pain 
Reason for PAIR  Disseminated hydatidosis; patient refused surgery  High surgical risk  New cyst in small liver remnant 
Number (n)  Multiple 
Location  Peritoneal hepatic  Right liver  Left liver 
Serology 
Number of PAIR 
Initial size (cm)  10 
Post-PAIR cyst size (cm)  3.3 
% reduction  70%  30%  35% 
Post-PAIR symptoms  Asymptomatic  Asymptomatic  Asymptomatic 
PAIR morbidity PAIR  No  No  No 
Hospitalization (days) 
Post-PAIR serology 
Recurrence  Yes  No  No 
Follow-up (months)  39  15  15 

EF: ejection fraction; PAIR: puncture, aspiration, injection, reaspiration.

Fig. 1.

(A) Hydatid cyst; (B) puncture; (C) aspiration; (D) reaspiration.

(0.24MB).
Fig. 2.

Patient from Fig. 1, 12 months after the PAIR technique.

(0.15MB).

Surgery is the only technique that is able to cure this pathology and the only option for patients with complicated HHC.1–9 Percutaneous treatment of HHC, usually combined with albendazole, has grown in popularity, and it is considered the best therapeutic option in many underdeveloped countries.1–6,8,9

The most widely recognized indications for PAIR are: CE1 and CE3a HHC, infected cysts, pregnancy, failed treatment with albendazole, inoperable patients or those who refuse surgery, and HHC recurrence after surgery.4,5 This technique has a recurrence rate of 0%–15%; the results are related with the type of HHC, which are poorer in multivesicular cysts and better in CE1 HHC larger than 5cm and CE3a.3–5 Contraindications include: CE4 and CE5 HHC, HHC that are inaccessible by puncture or high-risk, and HHC connected to the bile duct.5,6 The use of PAIR in CE2 and CE3b HHC is controversial.5

The benefits of PAIR include: diagnostic confirmation, elimination of parasitic material, low morbidity and almost no mortality, shorter hospitalization and lower cost than surgical techiques.3,5,8,9 The complications described are typical of any liver puncture (bleeding), while others are specific to PAIR: biliary fistula after cystic decompression, sclerosing cholangitis if there is passage of scolicidal solution to the bile duct, cyst infection, parasitic dissemination, systemic toxicity from the injected liquid and anaphylactic reactions.5,9 In cysts larger than 10cm, it is recommended to always leave in a drain tube for 48h.5

One of the disadvantages of PAIR is the follow-up evaluation, since a residual lesion remains and its degree of activity remains unknown.3,4 Kabaaalioglu et al. have created a classification in order to quantify the results after PAIR based on the volume lost and post-puncture radiological characteristics.4

Unlike other countries with endemic areas of hydatidosis, in Spain the use of PAIR is anecdotal, and surgery continues to be the main treatment.7 Asymptomatic patients or those who refuse surgery or in whom surgery is contraindicated due to comorbidities, treatment usually includes albendazole, but not PAIR. The problem arises in symptomatic patients who cannot be treated by surgery and when albendazole therapy has not provided good results or cannot be used due to intolerance or allergy. In this short series, we present patients with uncommon indications, since PAIR is usually used in other countries in patients with univesicular cysts that are uncomplicated and less complex.3,5

In conclusion, PAIR can be useful in patients with complex, symptomatic HHC that cannot be treated surgically, thereby avoiding interventions with high surgical risk. Although the short follow-up does not provide for long-term conclusions, we were able to resolve extreme situations with zero morbidity.

References
[1]
A. Giorgio, G. de Stefano, V. Esposito, G. Liorre, A. Di Sarno, V. Giorgio, et al.
Long-term results of percutaneous treatment of hydatid liver cysts: a single center 17 years experience.
Infection, 36 (2008), pp. 256-261
[2]
N. Gupta, A. Javed, S. Puri, S. Jain, S. Singh, A.K. Agarwk.
Hepatic hydatid: PAIR, drain or resect?.
J Gastrointest Surg, 15 (2011), pp. 1829-1836
[3]
E. Zerem, R. Jusufovic.
Percutaneous treatment of univesicular vs multivesicular hepatic hydatid cysts.
Surg Endosc, 20 (2006), pp. 1543-1547
[4]
A. Kabaalioglu, K. Çeken, E. Alimoglu, A. Apaydin.
Percutaneous imaging-guided treatment of hydatid liver cysts: do long-term results make it a first choice?.
Eur J Radiol, 59 (2006), pp. 65-73
[5]
E. Brunetti, P. Kern, D.A. Vuitton, Writing Panel for the WHO-IWGE.
Expert consensus for the diagnosis and treatment of cystic and alveolar echinococcosis in humans.
[6]
I. Rozanes, K. Guven, B. Acunas, A. Emre.
Cystic echinococcal liver disease: new insights into an old disease and an algorithm for therapy planning.
Cardiovasc Intervent Radiol, 30 (2007), pp. 1112-1116
[7]
J.M. Ramia, F. Ruiz, R. De la Plaza, P. Veguillas, J. Quiñones, J. García-Parreño.
Ambispective comparative study of two surgical strategies for liver hydatidosis.
World J Gastroenterol, 18 (2012), pp. 546-550
[8]
A. Giorgio, L. Tarantino, G. Stefano, G. Francica, N. Mariniello, N. Farella, et al.
Hydatid liver cyst: an 11-yesr experience of treatment with percutaneous aspiration and ethanol injection.
J Ultrasound Med, 20 (2001), pp. 729-738
[9]
A. Giorgio, A. Di Sarno, G. Stefano, N. Farella, P. Matteucci, U. Scognamiglio, et al.
Percutaneous treatment of hydatid liver cyst.
Recen Pat Anti-Infect Drug Disc, 4 (2009), pp. 29-36

Please cite this article as: Ramia JM, del Cerro J, de la Plaza R, Adel F, García-Parreño J. Punción, aspiración, instilación y re-aspiración en casos complejos de hidatidosis hepática. Cir Esp. 2015;93:e45–e47.

Copyright © 2013. AEC
Article options
Tools
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos

Quizás le interese:
10.1016/j.cireng.2019.03.016